Divalproex Sodium Delayed-Release Capsules USP, 125 mg have an estimated market size of US$ 61.1 million for twelve months ending September 2024 according to IQVIA
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
Difluprednate Ophthalmic Emulsion, 0.05% is a topical corticosteroid that is indicated in the treatment of inflammation and pain associated with ocular surgery
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
This product is indicated in coagulation disorders caused by vitamin K deficiency or interference with vitamin K activity.
Biocon Biologics is among the two pharmaceutical companies from India in the 93 companies featuring on the Asia IP Elite 2024 list
The approved product has an estimated market size of US$ 106 million for the twelve months ending October 2024, according to IQVIA
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
Reaffirms Lupin’s commitment to sustainable resource management
Subscribe To Our Newsletter & Stay Updated
